mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.02 |